Advertisement
Get ready for central vein sign and optical coherence tomography
How these new drugs fit into practice two years out from their first approvals
First U.S. cost-effectiveness analysis in decades supports more surgical evaluations
Mechanisms range from inflammation to infection of neurons
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Neurologic symptoms are a growing concern in hospitalized individuals
New research elucidates key role of WISP1 protein
$2 million will enable preclinical dose and efficacy testing of “compound 3”
Making the most of our evolving understanding of how the conditions intersect
A conversation on the state of physiatry with the AAPM&R’s Vice President
How to practice self-care during a healthcare crisis
Advertisement
Advertisement